Riliprubart Prefilled Pen (PFP)

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Polyneuropathy, Inflammatory Demyelinating, Chronic

Drug Information

Target Indication

Polyneuropathy, Inflammatory Demyelinating, Chronic

Clinical Trial

Last updated: 12/8/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNY

Sanofi

Related Pipeline

Sleep Initiation and Maintenance Disorders

Hemophilia A

Ulcerative Colitis

Alzheimer Disease

Influenza

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts